Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Rifampin"" wg kryterium: Temat


Tytuł :
In situ revascularization with rifampicin-soaked silver polyester graft for aortic infection: Results of a retrospective monocentric series of 18 cases.
Autorzy :
Vanbrugghe C; Vascular surgery department, CHU de Timone, 264, rue Saint-Pierre, 13385 Marseille, France; General and visceral surgery departement, hôpital Nord, chemin des Bourrely, 13015 Marseille, France.
Bartoli MA; Vascular surgery department, CHU de Timone, 264, rue Saint-Pierre, 13385 Marseille, France. Electronic address: .
Ouaissi M; Digestive surgery department, CHRU Tours, avenue de la république, 37170 Chambray-lès-Tours, France.
Sarlon G; Vascular surgery department, CHU de Timone, 264, rue Saint-Pierre, 13385 Marseille, France.
Amabile P; Vascular surgery department, CHU de Timone, 264, rue Saint-Pierre, 13385 Marseille, France.
Magnan PÉ; Vascular surgery department, CHU de Timone, 264, rue Saint-Pierre, 13385 Marseille, France.
Soler RJ; Vascular surgery department, CHU de Timone, 264, rue Saint-Pierre, 13385 Marseille, France.
Pokaż więcej
Źródło :
Journal de medecine vasculaire [J Med Vasc] 2020 Jul; Vol. 45 (4), pp. 177-183. Date of Electronic Publication: 2020 May 05.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Country of Publication: France NLM ID: 101709200 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2542-4513 (Print) Linking ISSN: 25424513 NLM ISO Abbreviation: J Med Vasc Subsets: MEDLINE
MeSH Terms :
Blood Vessel Prosthesis*/adverse effects
Polyesters*/adverse effects
Silver*/adverse effects
Aneurysm, Infected/*surgery
Anti-Bacterial Agents/*administration & dosage
Aortic Aneurysm/*surgery
Blood Vessel Prosthesis Implantation/*instrumentation
Prosthesis-Related Infections/*surgery
Rifampin/*administration & dosage
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Aneurysm, Infected/diagnostic imaging ; Aneurysm, Infected/microbiology ; Aneurysm, Infected/mortality ; Anti-Bacterial Agents/adverse effects ; Aortic Aneurysm/diagnostic imaging ; Aortic Aneurysm/microbiology ; Aortic Aneurysm/mortality ; Blood Vessel Prosthesis Implantation/adverse effects ; Blood Vessel Prosthesis Implantation/mortality ; Female ; France ; Hospital Mortality ; Humans ; Male ; Middle Aged ; Prosthesis Design ; Prosthesis-Related Infections/diagnostic imaging ; Prosthesis-Related Infections/microbiology ; Prosthesis-Related Infections/mortality ; Retrospective Studies ; Rifampin/adverse effects ; Risk Factors ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Successful use of rifampin in a patient with Stevens-Johnson syndrome to rifabutin.
Autorzy :
Yonkof JR; Department of Otolaryngology, Division of Allergy and Immunology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Tapke DE; Department of Otolaryngology, Division of Allergy and Immunology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Fox CC; Department of Otolaryngology, Division of Allergy and Immunology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Ogbogu PU; Department of Otolaryngology, Division of Allergy and Immunology, The Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address: .
Pokaż więcej
Źródło :
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2020 Jun; Vol. 124 (6), pp. 624-626. Date of Electronic Publication: 2020 Mar 10.
Typ publikacji :
Case Reports; Letter
Journal Info :
Publisher: American College of Allergy, Asthma, and Immunology Country of Publication: United States NLM ID: 9503580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4436 (Electronic) Linking ISSN: 10811206 NLM ISO Abbreviation: Ann. Allergy Asthma Immunol. Subsets: MEDLINE
MeSH Terms :
Antibiotics, Antitubercular/*adverse effects
Rifabutin/*adverse effects
Rifampin/*therapeutic use
Stevens-Johnson Syndrome/*drug therapy
Stevens-Johnson Syndrome/*etiology
Cross Reactions/immunology ; Humans ; Immunoglobulin E/immunology ; Male ; Middle Aged ; Rifampin/administration & dosage ; Treatment Outcome
Raport
Tytuł :
Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions.
Autorzy :
Ordonez AA; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Wang H; Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, MD, USA.
Magombedze G; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor University Medical Center and Texas Tech University Health Sciences Center, Dallas, TX, USA.
Ruiz-Bedoya CA; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Srivastava S; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor University Medical Center and Texas Tech University Health Sciences Center, Dallas, TX, USA.
Chen A; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Tucker EW; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Urbanowski ME; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pieterse L; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Fabian Cardozo E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Lodge MA; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Shah MR; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Holt DP; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Mathews WB; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Dannals RF; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gobburu JVS; Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, MD, USA.
Peloquin CA; Infectious Disease Pharmacokinetics Laboratory, Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, FL, USA.
Rowe SP; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gumbo T; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor University Medical Center and Texas Tech University Health Sciences Center, Dallas, TX, USA.
Ivaturi VD; Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, MD, USA.
Jain SK; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2020 Apr; Vol. 26 (4), pp. 529-534. Date of Electronic Publication: 2020 Feb 17.
Typ publikacji :
Clinical Study; Journal Article; Research Support, N.I.H., Extramural
Journal Info :
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat. Med. Subsets: MEDLINE
MeSH Terms :
Antitubercular Agents/*pharmacokinetics
Lung/*diagnostic imaging
Lung/*metabolism
Rifampin/*pharmacokinetics
Tuberculosis/*diagnosis
Tuberculosis/*drug therapy
Adult ; Animals ; Antitubercular Agents/administration & dosage ; Antitubercular Agents/blood ; Biological Availability ; Drug Therapy, Combination ; Female ; Humans ; Lung/drug effects ; Lung/pathology ; Male ; Mycobacterium tuberculosis/physiology ; Positron Emission Tomography Computed Tomography ; Rabbits ; Rifampin/administration & dosage ; Rifampin/blood ; Tissue Distribution ; Tuberculosis/metabolism ; Tuberculosis/pathology ; Tuberculosis, Pulmonary/diagnosis ; Tuberculosis, Pulmonary/drug therapy ; Tuberculosis, Pulmonary/metabolism ; Tuberculosis, Pulmonary/pathology
Czasopismo naukowe
Tytuł :
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Autorzy :
Phillips RO; Kwame Nkrumah University of Science and Technology, Kumasi Centre for Collaborative Research in Tropical Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Robert J; Centre d'immunologie et des maladies infectieuses, Inserm, Sorbonne Université, Bactériologie site Pitié, AP-HP Sorbonne Université, Centre National de Référence des Mycobactéries, Paris, France.
Abass KM; Agogo Presbyterian Hospital, Agogo, Ghana.
Thompson W; Agogo Presbyterian Hospital, Agogo, Ghana.
Sarfo FS; Kwame Nkrumah University of Science and Technology, Kumasi Centre for Collaborative Research in Tropical Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Wilson T; Nkawie-Toaso Government Hospital, Ghana.
Sarpong G; Dunkwa Government Hospital, Dunkwa-on-Offin, Ghana.
Gateau T; Centre de diagnostic et de traitement de la lèpre et de l'Ulcère de Buruli Madeleine et Raoul Follereau, Ouémé-Plateau, Pobè, Bénin.
Chauty A; Centre de diagnostic et de traitement de la lèpre et de l'Ulcère de Buruli Madeleine et Raoul Follereau, Ouémé-Plateau, Pobè, Bénin.
Omollo R; Drugs for Neglected Diseases initiative, Africa Regional Office, Nairobi, Kenya.
Ochieng Otieno M; Drugs for Neglected Diseases initiative, Africa Regional Office, Nairobi, Kenya.
Egondi TW; Drugs for Neglected Diseases initiative, Africa Regional Office, Nairobi, Kenya.
Ampadu EO; National Buruli ulcer Control Programme, Ghana Health Service, Accra, Ghana.
Agossadou D; Programme National de Lutte contre la lèpre et l'Ulcère de Buruli, Cotonou, Benin.
Marion E; Centre de recherche en cancérologie et immunologie Nantes-Angers, French National Institute of Health and Medical Research, Université d'Angers, Angers, France.
Ganlonon L; Centre de diagnostic et de traitement de la lèpre et de l'Ulcère de Buruli Madeleine et Raoul Follereau, Ouémé-Plateau, Pobè, Bénin.
Wansbrough-Jones M; Institute of Infection and Immunity, St George's University of London, London, UK.
Grosset J; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Macdonald JM; Department of Dermatology & Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA; Hospital Bernard Meys Project Medishare, Port-au-Prince, Haiti.
Treadwell T; Institute for Advanced Wound Care, Montgomery, AL, USA.
Saunderson P; American Leprosy Missions, Greenville, SC, USA.
Paintsil A; Reconstructive and Plastic Surgery Unit, Korle-BU Teaching Hospital, Accra, Ghana.
Lehman L; American Leprosy Missions, Greenville, SC, USA.
Frimpong M; Kwame Nkrumah University of Science and Technology, Kumasi Centre for Collaborative Research in Tropical Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Sarpong NF; Kwame Nkrumah University of Science and Technology, Kumasi Centre for Collaborative Research in Tropical Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Saizonou R; WHO, Country Office for Benin, Cotonou, Benin.
Tiendrebeogo A; WHO, Regional Office for Africa, Brazzaville, Republic of the Congo.
Ohene SA; WHO, Country Office for Ghana, Accra, Ghana.
Stienstra Y; Department of Medicine/Infectious Diseases, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.
Asiedu KB; Department of Neglected Tropical Diseases, WHO, Geneva, Switzerland.
van der Werf TS; Department of Medicine/Infectious Diseases, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands. Electronic address: .
Pokaż więcej
Corporate Authors :
study team
Źródło :
Lancet (London, England) [Lancet] 2020 Apr 18; Vol. 395 (10232), pp. 1259-1267. Date of Electronic Publication: 2020 Mar 12.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Buruli Ulcer/*drug therapy
Clarithromycin/*administration & dosage
Rifampin/*administration & dosage
Streptomycin/*administration & dosage
Administration, Oral ; Adolescent ; Adult ; Anti-Bacterial Agents ; Benin ; Child ; Clarithromycin/adverse effects ; Delayed-Action Preparations/administration & dosage ; Delayed-Action Preparations/adverse effects ; Drug Therapy, Combination ; Female ; Ghana ; Humans ; Male ; Rifampin/adverse effects ; Streptomycin/adverse effects ; Wound Healing/drug effects ; Young Adult
Czasopismo naukowe
Tytuł :
Metabolomics describes previously unknown toxicity mechanisms of isoniazid and rifampicin.
Autorzy :
Combrink M; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom, 2531, South Africa.
Loots DT; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom, 2531, South Africa.
du Preez I; Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom, 2531, South Africa. Electronic address: .
Pokaż więcej
Źródło :
Toxicology letters [Toxicol Lett] 2020 Apr 01; Vol. 322, pp. 104-110. Date of Electronic Publication: 2020 Jan 22.
Typ publikacji :
Journal Article; Review
Journal Info :
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7709027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3169 (Electronic) Linking ISSN: 03784274 NLM ISO Abbreviation: Toxicol. Lett. Subsets: MEDLINE
MeSH Terms :
Antitubercular Agents/*toxicity
Drug-Related Side Effects and Adverse Reactions/*etiology
Isoniazid/*toxicity
Metabolomics/*methods
Rifampin/*toxicity
Toxicity Tests/*methods
Animals ; Antitubercular Agents/metabolism ; Biomarkers/metabolism ; Biotransformation ; Drug-Related Side Effects and Adverse Reactions/diagnosis ; Drug-Related Side Effects and Adverse Reactions/metabolism ; Humans ; Isoniazid/metabolism ; Rifampin/metabolism ; Risk Assessment
Czasopismo naukowe
Tytuł :
Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis.
Autorzy :
Ma H; Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing, China.
Cheng J; Chongqing Key Laboratory of Pediatrics, Chongqing, China.; Department of Children's Hospital of Chongqing Medical University of Education, Key Laboratory of Child Development and Disorders, Chongqing, China.
Peng L; Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing, China.
Gao Y; Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing, China.
Zhang G; Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing, China.
Luo Z; Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing, China.; Chongqing Key Laboratory of Pediatrics, Chongqing, China.; Department of Children's Hospital of Chongqing Medical University of Education, Key Laboratory of Child Development and Disorders, Chongqing, China.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Mar 19; Vol. 15 (3), pp. e0230383. Date of Electronic Publication: 2020 Mar 19 (Print Publication: 2020).
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS ONE Subsets: MEDLINE
MeSH Terms :
Bacteremia/*drug therapy
Bacteremia/*microbiology
Rifampin/*therapeutic use
Staphylococcal Infections/*drug therapy
Staphylococcal Infections/*microbiology
Staphylococcus aureus/*physiology
Bacteremia/mortality ; Humans ; Publication Bias ; Randomized Controlled Trials as Topic ; Rifampin/pharmacology ; Risk ; Staphylococcal Infections/mortality ; Staphylococcus aureus/drug effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Effect of Xpert MTB/RIF testing introduction and favorable outcome predictors for tuberculosis treatment among HIV infected adults in rural southern Mozambique. A retrospective cohort study.
Autorzy :
Nacarapa E; Chókwè Carmelo Hospital-Daughters of Charity, Saint Vincent of Paul, Chókwè, Gaza Province, Mozambique.; Tinpswalo Association, Research Unit, Vincentian Association to Fight AIDS and TB, Chókwè, Gaza Province, Mozambique.
Muchiri E; The Aurum Institute, Parktown, South Africa.
Moon TD; Department of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.; Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Charalambous S; The Aurum Institute, Parktown, South Africa.; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Verdu ME; Chókwè Carmelo Hospital-Daughters of Charity, Saint Vincent of Paul, Chókwè, Gaza Province, Mozambique.
Ramos JM; Department of Internal Medicine. University General Hospital of Alicante and Miguel Hernandez University of Elche, Alicante, Spain.
Valverde EJ; The Aurum Institute, Maputo, Mozambique.; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Mar 09; Vol. 15 (3), pp. e0229995. Date of Electronic Publication: 2020 Mar 09 (Print Publication: 2020).
Typ publikacji :
Journal Article
Journal Info :
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS ONE Subsets: MEDLINE
MeSH Terms :
HIV Infections/*complications
Rifampin/*pharmacology
Rural Population/*statistics & numerical data
Tuberculosis/*diagnosis
Tuberculosis/*drug therapy
Adolescent ; Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Mozambique ; Retrospective Studies ; Rifampin/therapeutic use ; Survival Analysis ; Treatment Outcome ; Tuberculosis/complications ; Young Adult
Czasopismo naukowe
Tytuł :
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials.
Autorzy :
Campbell JR; Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill International TB Centre, McGill University Health Centre Research Institute, McGill University, Montréal, QC, Canada; Department of Epidemiology and Biostatistics, McGill University, Montréal, QC, Canada.
Trajman A; Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill International TB Centre, McGill University Health Centre Research Institute, McGill University, Montréal, QC, Canada; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Cook VJ; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Provincial TB Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada.
Johnston JC; Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill International TB Centre, McGill University Health Centre Research Institute, McGill University, Montréal, QC, Canada; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Provincial TB Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada.
Adjobimey M; National Hospitalier Universitaire de Pneumo-Phtisiologie, Cotonou, Benin.
Ruslami R; Department of Biomedical Sciences, Division of Pharmacology and Therapy, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Eisenbeis L; University of Alberta, Edmonton, AB, Canada.
Fregonese F; Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill International TB Centre, McGill University Health Centre Research Institute, McGill University, Montréal, QC, Canada.
Valiquette C; Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill International TB Centre, McGill University Health Centre Research Institute, McGill University, Montréal, QC, Canada.
Benedetti A; Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill International TB Centre, McGill University Health Centre Research Institute, McGill University, Montréal, QC, Canada; Department of Epidemiology and Biostatistics, McGill University, Montréal, QC, Canada.
Menzies D; Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill International TB Centre, McGill University Health Centre Research Institute, McGill University, Montréal, QC, Canada; Department of Epidemiology and Biostatistics, McGill University, Montréal, QC, Canada. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Mar; Vol. 20 (3), pp. 318-329. Date of Electronic Publication: 2019 Dec 19.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
MeSH Terms :
Antitubercular Agents/*adverse effects
Drug-Related Side Effects and Adverse Reactions/*epidemiology
Drug-Related Side Effects and Adverse Reactions/*pathology
Isoniazid/*adverse effects
Latent Tuberculosis/*drug therapy
Rifampin/*adverse effects
Adult ; Africa ; Americas ; Antitubercular Agents/therapeutic use ; Asia ; Australia ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Humans ; Isoniazid/therapeutic use ; Randomized Controlled Trials as Topic ; Rifampin/therapeutic use ; Risk Factors
Czasopismo naukowe
Tytuł :
Single-dose rifampicin and BCG to prevent leprosy.
Autorzy :
Lockwood DN; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: .
De Barros B; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Walker SL; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom; Hospital for Tropical Diseases and Department of Dermatology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2020 Mar; Vol. 92, pp. 269-270. Date of Electronic Publication: 2020 Jan 31.
Typ publikacji :
Letter; Comment
Journal Info :
Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511 (Electronic) Linking ISSN: 12019712 NLM ISO Abbreviation: Int. J. Infect. Dis. Subsets: MEDLINE
MeSH Terms :
Leprosy*
Rifampin*
BCG Vaccine ; Chemoprevention ; Humans ; Immunization
Opinia redakcyjna
Tytuł :
Development and in vitro characterization of rifapentine microsphere-loaded bone implants: a sustained drug delivery system.
Autorzy :
Wang Z; Department of Orthopeadics, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China.
Song X; Department of Orthopeadics, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China; Department of Orthopeadics, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China. .
Yang H; The Linfen Center for Disease Control and Prevention, Linfen 041000, China.
Maimaitiaili A; Department of Orthopeadics, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China.
Wang T; Department of Orthopeadics, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China.
Pokaż więcej
Źródło :
Annals of palliative medicine [Ann Palliat Med] 2020 Mar; Vol. 9 (2), pp. 375-387. Date of Electronic Publication: 2020 Mar 17.
Typ publikacji :
Journal Article
Journal Info :
Publisher: AME Publishing Company Country of Publication: China NLM ID: 101585484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2224-5839 (Electronic) Linking ISSN: 22245820 NLM ISO Abbreviation: Ann Palliat Med Subsets: MEDLINE
MeSH Terms :
Antitubercular Agents/*pharmacology
Mesenchymal Stem Cells/*drug effects
Rifampin/*analogs & derivatives
Tuberculosis, Osteoarticular/*drug therapy
Animals ; Cell Differentiation ; Cell Proliferation ; Delayed-Action Preparations ; Drug Delivery Systems ; Flow Cytometry ; Osteogenesis/drug effects ; Rabbits ; Rifampin/pharmacology
Czasopismo naukowe
Tytuł :
Reply to: Single-dose rifampicin and BCG to prevent leprosy.
Autorzy :
Richardus JH; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: .
Geluk A; Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands.
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2020 Mar; Vol. 92, pp. 271-272. Date of Electronic Publication: 2020 Jan 31.
Typ publikacji :
Letter; Comment
Journal Info :
Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511 (Electronic) Linking ISSN: 12019712 NLM ISO Abbreviation: Int. J. Infect. Dis. Subsets: MEDLINE
MeSH Terms :
Leprosy*
Rifampin*
BCG Vaccine ; Humans ; Vaccination
Opinia redakcyjna
Tytuł :
Novel Approach for Transdermal Delivery of Rifampicin to Induce Synergistic Antimycobacterial Effects Against Cutaneous and Systemic Tuberculosis Using a Cationic Nanoemulsion Gel.
Autorzy :
Hussain A; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Altamimi MA; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Alshehri S; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Imam SS; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Shakeel F; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Singh SK; Department of Pharmaceutical Sciences, Birla Institute of Technology, Ranchi, Jharkhand, India.
Pokaż więcej
Źródło :
International journal of nanomedicine [Int J Nanomedicine] 2020 Feb 14; Vol. 15, pp. 1073-1094. Date of Electronic Publication: 2020 Feb 14 (Print Publication: 2020).
Typ publikacji :
Journal Article
Journal Info :
Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE
MeSH Terms :
Antitubercular Agents/*administration & dosage
Emulsions/*administration & dosage
Rifampin/*administration & dosage
Tuberculosis/*drug therapy
Acrylic Resins/chemistry ; Administration, Cutaneous ; Animals ; Antitubercular Agents/pharmacokinetics ; Antitubercular Agents/pharmacology ; Biological Availability ; Caprylates/chemistry ; Cations/chemistry ; Emulsions/pharmacology ; Excipients/chemistry ; Gels/chemistry ; Gels/pharmacology ; Glycerides/chemistry ; Mycobacterium/drug effects ; Nanostructures/administration & dosage ; Nanostructures/chemistry ; Particle Size ; Rats, Sprague-Dawley ; Rifampin/pharmacokinetics ; Rifampin/pharmacology ; Skin/drug effects ; Tuberculosis, Cutaneous/drug therapy
Czasopismo naukowe
Tytuł :
Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis.
Autorzy :
Yu YY; Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.; Department of Clinical Laboratory, Changhua Hospital, Changhua 513, Taiwan.
Tsao SM; Division of Chest, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 402, Taiwan.; Institute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung 402, Taiwan.
Yang WT; Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung 403, Taiwan.
Huang WC; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 407, Taiwan.; Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli 356, Taiwan.; Department of Life Sciences, National Chung Hsing University, Taichung 402, Taiwan.; Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung 407, Taiwan.
Lin CH; Division of Chest, Changhua Christian Hospital, Changhua 500, Taiwan.
Chen WW; Department of Health, Pulmonary and Critical Care Unit, Changhua Hospital, Changhua 500, Taiwan.
Yang SF; Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.; Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
Chiou HL; School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 402, Taiwan.; Department of Clinical Laboratory, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
Huang YW; Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.; Department of Health, Pulmonary and Critical Care Unit, Changhua Hospital, Changhua 500, Taiwan.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2019 Dec 27; Vol. 17 (1). Date of Electronic Publication: 2019 Dec 27.
Typ publikacji :
Journal Article
Journal Info :
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE
MeSH Terms :
Polymorphism, Single Nucleotide*
Antitubercular Agents/*therapeutic use
Arylamine N-Acetyltransferase/*genetics
Cytochrome P-450 Enzyme System/*genetics
Isoniazid/*therapeutic use
Latent Tuberculosis/*drug therapy
Rifampin/*analogs & derivatives
Adult ; Antitubercular Agents/administration & dosage ; Antitubercular Agents/adverse effects ; Drug Administration Schedule ; Drug Therapy, Combination ; Drug-Related Side Effects and Adverse Reactions ; Female ; Humans ; Isoniazid/administration & dosage ; Isoniazid/adverse effects ; Male ; Odds Ratio ; Rifampin/administration & dosage ; Rifampin/adverse effects ; Rifampin/therapeutic use
Czasopismo naukowe
Tytuł :
Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.
Autorzy :
Foreman TW; Tulane National Primate Research Center, Tulane University School of Medicine, Covington, Louisiana.
Bucşan AN; Tulane National Primate Research Center, Tulane University School of Medicine, Covington, Louisiana.
Mehra S; Tulane National Primate Research Center, Tulane University School of Medicine, Covington, Louisiana.
Peloquin C; University of Florida College of Pharmacy, Gainesville, Florida.
Doyle LA; Tulane National Primate Research Center, Tulane University School of Medicine, Covington, Louisiana.
Russell-Lodrigue K; Tulane National Primate Research Center, Tulane University School of Medicine, Covington, Louisiana.
Gandhi NR; Rollins School of Public Health and.
Altman J; Emory Vaccine Center and Yerkes National Primate Center, Emory University, Atlanta, Georgia.; Department of Microbiology and Immunology and.
Day CL; Emory Vaccine Center and Yerkes National Primate Center, Emory University, Atlanta, Georgia.; Department of Microbiology and Immunology and.
Ernst JD; Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, California; and.
Blumberg HM; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Rengarajan J; Emory Vaccine Center and Yerkes National Primate Center, Emory University, Atlanta, Georgia.; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Kaushal D; Tulane National Primate Research Center, Tulane University School of Medicine, Covington, Louisiana.; Southwest National Primate Research Center, Texas Biomedical Research Center, San Antonio, Texas.
Pokaż więcej
Źródło :
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Feb 15; Vol. 201 (4), pp. 469-477.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
Journal Info :
Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am. J. Respir. Crit. Care Med. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Antibiotics, Antitubercular/*therapeutic use
Antitubercular Agents/*therapeutic use
Isoniazid/*therapeutic use
Latent Tuberculosis/*drug therapy
Mycobacterium tuberculosis/*drug effects
Rifampin/*analogs & derivatives
Tuberculosis/*drug therapy
Animals ; Drug Therapy, Combination ; Macaca ; Models, Animal ; Rifampin/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Accuracy of Xpert MTB/RIF Ultra for the Diagnosis of Pleural TB in a Multicenter Cohort Study.
Autorzy :
Wang G; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Wang S; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Yang X; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Sun Q; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Jiang G; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Huang M; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Huo F; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Ma Y; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Chen X; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China. Electronic address: .
Huang H; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Pokaż więcej
Źródło :
Chest [Chest] 2020 Feb; Vol. 157 (2), pp. 268-275. Date of Electronic Publication: 2019 Aug 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1931-3543 (Electronic) Linking ISSN: 00123692 NLM ISO Abbreviation: Chest Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Antibiotics, Antitubercular*
Rifampin*
Drug Resistance, Microbial/*genetics
Mycobacterium tuberculosis/*genetics
Tuberculosis, Multidrug-Resistant/*diagnosis
Tuberculosis, Pleural/*diagnosis
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Culture Techniques ; Female ; Humans ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Nucleic Acid Amplification Techniques ; Pleural Effusion ; Polymerase Chain Reaction ; Predictive Value of Tests ; Sensitivity and Specificity ; Young Adult
Czasopismo naukowe
Tytuł :
Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia.
Autorzy :
Alemu A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia. .
Tadesse M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Seid G; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Mollalign H; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Eshetu K; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Sinshaw W; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Abebaw Y; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Amare M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Dagne B; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Diriba G; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Yenew B; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Getu M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Zerihun B; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 Jan 30; Vol. 20 (1), pp. 87. Date of Electronic Publication: 2020 Jan 30.
Typ publikacji :
Journal Article; Review
Journal Info :
Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect. Dis. Subsets: MEDLINE
MeSH Terms :
Mutation*
Drug Resistance, Bacterial/*genetics
Genetic Testing/*methods
Mycobacterium tuberculosis/*genetics
Rifampin/*therapeutic use
Tuberculosis/*diagnosis
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Codon/genetics ; DNA/analysis ; Ethiopia ; Female ; Humans ; Infant ; Male ; Middle Aged ; Retrospective Studies ; Rifampin/adverse effects ; Sensitivity and Specificity ; Sputum/microbiology ; Tuberculosis/microbiology ; Young Adult
Czasopismo naukowe
Tytuł :
World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
Autorzy :
Lazo-Porras M; CONEVID Unidad de Conocimiento y Evidencia, School of Medicine 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Lima 31, Peru.; Division of Tropical and Humanitarian Medicine, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
Prutsky GJ; CONEVID Unidad de Conocimiento y Evidencia, School of Medicine 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Lima 31, Peru.; Department of Pediatrics, Mayo Clinic Health System, Mankato, MN, USA.
Barrionuevo P; CONEVID Unidad de Conocimiento y Evidencia, School of Medicine 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Lima 31, Peru.
Tapia JC; CONEVID Unidad de Conocimiento y Evidencia, School of Medicine 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Lima 31, Peru.; Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, and Universitat Autònoma de Barcelona, Barcelona, Spain.
Ugarte-Gil C; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.; School of Medicine 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Lima, Peru.; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Ponce OJ; CONEVID Unidad de Conocimiento y Evidencia, School of Medicine 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Lima 31, Peru.
Acuña-Villaorduña A; CONEVID Unidad de Conocimiento y Evidencia, School of Medicine 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Lima 31, Peru.; Montefiore Medical Center-Albert Einstein College of Medicine, Bronx, New York, USA.
Domecq JP; CONEVID Unidad de Conocimiento y Evidencia, School of Medicine 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Lima 31, Peru.; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
De la Cruz-Luque C; CONEVID Unidad de Conocimiento y Evidencia, School of Medicine 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Lima 31, Peru.; Cardiology division, Jackson Memorial Hospital, Miami, Florida, USA.
Prokop LJ; Evidence-based Practice Center, Mayo Clinic, Rochester, MN, USA.
Málaga G; CONEVID Unidad de Conocimiento y Evidencia, School of Medicine 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Av. Honorio Delgado 430, Lima 31, Peru. .; School of Medicine 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Lima, Peru. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 Jan 20; Vol. 20 (1), pp. 62. Date of Electronic Publication: 2020 Jan 20.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
Journal Info :
Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect. Dis. Subsets: MEDLINE
MeSH Terms :
World Health Organization*
Leprostatic Agents/*therapeutic use
Leprosy, Multibacillary/*drug therapy
Leprosy, Paucibacillary/*drug therapy
Minocycline/*therapeutic use
Ofloxacin/*therapeutic use
Rifampin/*therapeutic use
Adolescent ; Adult ; Aged ; Child ; Clinical Protocols ; Drug Therapy, Combination/adverse effects ; Female ; Humans ; Leprostatic Agents/adverse effects ; Male ; Middle Aged ; Minocycline/adverse effects ; Mycobacterium leprae/drug effects ; Mycobacterium leprae/isolation & purification ; Neglected Diseases/drug therapy ; Ofloxacin/adverse effects ; Recurrence ; Rifampin/adverse effects ; Treatment Failure ; Young Adult
Czasopismo naukowe
Tytuł :
Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.
Autorzy :
Ortuno-Gutierrez N; Projects Department, Damien Foundation, Boulevard Leopold II, 263, PO B-1081, Brussels, Belgium. .
Younoussa A; National Tuberculosis and Leprosy control Program, Moroni, Union of the Comoros.
Randrianantoandro A; National Leprosy control Programme, Antananarivo, Madagascar.
Braet S; Institute of Tropical Medicine, Antwerp, Belgium.
Cauchoix B; Raoul Follereau, Antananarivo, Madagascar.
Ramboarina S; Raoul Follereau, Antananarivo, Madagascar.
Baco A; National Tuberculosis and Leprosy control Program, Moroni, Union of the Comoros.
Mzembaba A; National Tuberculosis and Leprosy control Program, Moroni, Union of the Comoros.
Salim Z; National Tuberculosis and Leprosy control Program, Moroni, Union of the Comoros.
Amidy M; National Tuberculosis and Leprosy control Program, Moroni, Union of the Comoros.
Grillone S; National Tuberculosis and Leprosy control Program, Moroni, Union of the Comoros.
Richardus JH; Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
de Jong BC; Institute of Tropical Medicine, Antwerp, Belgium.
Hasker E; Institute of Tropical Medicine, Antwerp, Belgium.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2019 Dec 05; Vol. 19 (1), pp. 1033. Date of Electronic Publication: 2019 Dec 05.
Typ publikacji :
Clinical Trial Protocol; Journal Article
Journal Info :
Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect. Dis. Subsets: MEDLINE
MeSH Terms :
Leprostatic Agents/*therapeutic use
Leprosy/*prevention & control
Post-Exposure Prophylaxis/*methods
Rifampin/*therapeutic use
Child, Preschool ; Comoros/epidemiology ; Family Characteristics ; Female ; Humans ; Incidence ; Leprostatic Agents/administration & dosage ; Leprosy/epidemiology ; Madagascar/epidemiology ; Male ; Randomized Controlled Trials as Topic ; Rifampin/administration & dosage
Czasopismo naukowe
Tytuł :
Latent tuberculosis treatment completion rates from prescription drug administrative data.
Autorzy :
Plourde PJ; Department of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada. .; Department of Medical Microbiology and Infectious Diseases, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada. .; Integrated Tuberculosis Services, Winnipeg Regional Health Authority, 490 Hargrave Street, Winnipeg, Manitoba, R3A 0X7, Canada. .
Basham CA; British Columbia Centre for Disease Control and School of Population and Public Health, University of British Columbia, Vancouver, Canada.
Derksen S; Manitoba Centre for Health Policy, Winnipeg, Canada.
Schultz J; Manitoba Centre for Health Policy, Winnipeg, Canada.
McCulloch S; Manitoba Centre for Health Policy, Winnipeg, Canada.
Larcombe L; Department of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.; Department of Medical Microbiology and Infectious Diseases, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Kinew KA; Nanaandawewigamig, First Nations Health and Social Secretariat of Manitoba, Winnipeg, Canada.
Lix LM; Department of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.; Manitoba Centre for Health Policy, Winnipeg, Canada.
Pokaż więcej
Źródło :
Canadian journal of public health = Revue canadienne de sante publique [Can J Public Health] 2019 Dec; Vol. 110 (6), pp. 705-713. Date of Electronic Publication: 2019 Jul 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Springer Nature Country of Publication: Switzerland NLM ID: 0372714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1920-7476 (Electronic) Linking ISSN: 00084263 NLM ISO Abbreviation: Can J Public Health Subsets: MEDLINE
MeSH Terms :
Antitubercular Agents/*therapeutic use
Isoniazid/*therapeutic use
Latent Tuberculosis/*drug therapy
Prescription Drugs/*therapeutic use
Rifampin/*analogs & derivatives
Treatment Adherence and Compliance/*statistics & numerical data
Adolescent ; Adult ; Age Factors ; Aged ; Child ; Child, Preschool ; Databases, Factual ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Manitoba ; Middle Aged ; Rifampin/therapeutic use ; Young Adult
Czasopismo naukowe
Tytuł :
Organic Anion-Transporting Polypeptide Genes Are Not Induced by the Pregnane X Receptor Activator Rifampin: Studies in Hepatocytes In Vitro and in Monkeys In Vivo.
Autorzy :
Niu C; Drug Metabolism, Gilead Sciences, Foster City, California.
Wang Y; Drug Metabolism, Gilead Sciences, Foster City, California.
Zhao X; Drug Metabolism, Gilead Sciences, Foster City, California.
Tep S; Drug Metabolism, Gilead Sciences, Foster City, California.
Murakami E; Drug Metabolism, Gilead Sciences, Foster City, California.
Subramanian R; Drug Metabolism, Gilead Sciences, Foster City, California.
Smith B; Drug Metabolism, Gilead Sciences, Foster City, California.
Lai Y; Drug Metabolism, Gilead Sciences, Foster City, California .
Pokaż więcej
Źródło :
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2019 Dec; Vol. 47 (12), pp. 1433-1442. Date of Electronic Publication: 2019 Oct 03.
Typ publikacji :
Journal Article
Journal Info :
Publisher: American Society for Pharmacology and Experimental Therapeutics, etc.] Country of Publication: United States NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab. Dispos. Subsets: MEDLINE
MeSH Terms :
Gene Expression/*drug effects
Hepatocytes/*drug effects
Organic Anion Transporters/*genetics
Pregnane X Receptor/*agonists
Rifampin/*pharmacology
Animals ; Antipyrine/blood ; Antipyrine/pharmacokinetics ; Area Under Curve ; Cells, Cultured ; Hepatocytes/metabolism ; Humans ; Macaca fascicularis ; Male ; Quinolines/blood ; Quinolines/pharmacokinetics ; Rifampin/blood ; Species Specificity
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies